USP/IQ Consortium Summit: Bayesian Approaches in Chemistry Manufacturing Control (CMC)
December 10, 2024 - December 10, 2024
Hybrid Summit
Location: US Pharmacopeial Convention (In-person); Virtual platform
USP/IQ Consortium Summit: Bayesian Approaches in Chemstry Manufacturing Control (CMC)
Overview:
Join industry, compendial, regulatory and scientific experts at the USP / IQ Consortium summit on December 10, 2024.
Objective:
Experts from industry will convene to discuss the history and importance of Bayesian statistical approaches in Chemistry Manufacturing Control (CMC) development and lifecycle of pharmaceuticals. This discussion will address the benefits of using Bayesian statistical approaches to both patients and industry. Stakeholders will exchange knowledge and strategies to enhance understanding and acceptance of Bayesian statistical approaches in pharmaceutical development.
Learn more and regster now, seating is limited!
Who Should Participate:
- IQ CMC SLG members
- FDA reviewers, both statisticians and non-statisticians
- Academic researchers and students
Reference Materials:
- Agenda
- PowerPoint presentations are currently being finalized and will be made available to participants approximately 2-3 weeks prior to the summit.
Contact M Patricia Gaitan for registration or logistical assistance.
For information or to suggest additional stakeholder topics related to USP General Chapters please contact us at gc@usp.org.